Fatal miliary Coccidioidomycosis in a patient receiving infliximab therapy: A case report

Journal of Medical Case Reports

Volumn 1, Issue , 2007, Pages

  Rogan, Mark P ^a   Thomas, Karl ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPHOTERICIN; ANTIBIOTIC AGENT; CEFALEXIN; CLINDAMYCIN; INFLIXIMAB; LEVOFLOXACIN; METHOTREXATE; OXYGEN; TUBERCULIN; TUMOR NECROSIS FACTOR ANTIBODY;

AGED; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CASE REPORT; CELLULITIS; CLINICAL FEATURE; COCCIDIOIDES; COCCIDIOIDOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENDEMIC DISEASE; FATALITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; LABORATORY TEST; LUNG ANGIOGRAPHY; LUNG LAVAGE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PUNCH BIOPSY; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; RHEUMATOID ARTHRITIS; SKIN ULCER; THORAX RADIOGRAPHY; TUBERCULIN TEST; UNITED STATES;

EID: 44949169490     PISSN: 17521947     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-1-79     Document Type: Article

References (10)

1. Booth AD Jayne DR Kharbanda RK McEniery CM Mackenzie IS Brown J Wilkinson IB Infliximab improves endothelial dysfunction in systemic vasculitis: A model of vascular inflammation Circulation 2004, 109(14):1718-1723. 10.1161/01.CIR.0000124720.18538.DD 15037536
2. Baughman RP Drent M Kavuru M Judson MA Costabel U du Bois R Albera C Brutsche M Davis G Donohue JF Muller-Quernheim J Schlenker-Herceg R Flavin S Lo KH Oemar B Barnathan ES Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement Am J Respir Crit Care Med 2006, 174(7):795-802. 10.1164/rccm.200603-402OC 16840744
3. Desai SB Furst DE Problems encountered during anti-tumour necrosis factor therapy Best Pract Res Clin Rheumatol 2006, 20(4):757-790. 10.1016/j.berh.2006.06.002 16979537
4. Chang JT Lichtenstein GR Drug insight: Antagonists of tumor-necrosis factor-alpha in the treatment of inflammatory bowel disease Nat Clin Pract Gastroenterol Hepatol 2006, 3(4):220-228. 10.1038/ncpgasthep0447 16582964
5. Saubolle MA McKellar PP Sussland D Epidemiologic, Clinical and Diagnostic Aspects of Coccidioidomycosis J Clin Microbiol 2006. 1828958 17108067
6. Hector RF Laniado-Laborin R Coccidioidomycosis - a fungal disease of the Americas PLoS Med 2005, 2(1):e2. 545195 15696207 10.1371/ journal.pmed.0020002
7. DiCaudo DJ Coccidioidomycosis: A review and update J Am Acad Dermatol 2006, 55(6):929-42.; quiz 943-5 10.1016/j.jaad.2006.04.039 17110216
8. Blair JE Logan JL Coccidioidomycosis in solid organ transplantation Clin Infect Dis 2001, 33(9):1536-1544. 10.1086/323463 11588699
9. Bongartz T Sutton AJ Sweeting MJ Buchan I Matteson EL Montori V Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: Systematic review and meta-analysis of rare harmful effects in randomized controlled trials Jama 2006, 295(19):2275-2285. 10.1001/jama.295.19.2275 16705109
10. Bergstrom L Yocum DE Ampel NM Villanueva I Lisse J Gluck O Tesser J Posever J Miller M Araujo J Kageyama DM Berry M Karl L Yung CM Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists Arthritis Rheum 2004, 50(6):1959-1966. 10.1002/ art.20454 15188373